1-4 of 4
John S Manavalan
Close
Sort by
Journal Articles

Tolinapant (ASTX660), a Non-Peptidomimetic Antagonist of cIAP1/2 and XIAP, and the HDAC Inhibitor Romidepsin Are Synergistic in in Vitro Models of T Cell Lymphoma

John S Manavalan, Ipsita Pal, Aidan Pursley, George A. Ward, Tomoko Smyth, Martin Sims, David J Feith, Thomas P. Loughran, Jr., Owen A. O'Connor, Enrica Marchi
Journal: Blood
Blood (2021) 138 (Supplement 1): 4356.
https://doi.org/10.1182/blood-2021-153451
Published: 2021
Journal Articles

Targeting MYD88-Mutant DLBCL with IRAKIMiDs: A Comparison to IRAK4 Kinase Inhibition and Evaluation of Synergy with Rational Combinations

Jennifer Kimberly Lue, MD, John S Manavalan, MD, Christine Klaus, BS, Rahul Kanik, PhD, Andre M. Grilo, PhD, Alice McDonald, PhD, Jared Gollob, PhD MD, Duncan Walker, PhD, Owen A. O'Connor, MD PhD, Nello Mainolfi, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12.
https://doi.org/10.1182/blood-2020-135898
Published: 2020
Journal Articles

Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts

Maria Krevvata, Barbara C. Silva, John S. Manavalan, Marta Galan-Diez, Aruna Kode, Brya Grace Matthews, David Park, Chiyuan A. Zhang, Naomi Galili, Thomas L. Nickolas, David W. Dempster, William Dougall, Julie Teruya-Feldstein, Aris N. Economides, Ivo Kalajzic, Azra Raza, Ellin Berman, Siddhartha Mukherjee, Govind Bhagat, Stavroula Kousteni
Journal: Blood
Blood (2014) 124 (18): 2834–2846.
https://doi.org/10.1182/blood-2013-07-517219
Published: 2014
Includes: Supplemental data
Journal Articles

Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria

Anastasios Karadimitris, John S. Manavalan, Howard T. Thaler, Rosario Notaro, David J. Araten, Khedoudja Nafa, Irene A.G. Roberts, Marc E. Weksler, Lucio Luzzatto
Journal: Blood
Blood (2000) 96 (7): 2613–2620.
https://doi.org/10.1182/blood.V96.7.2613
Published: 2000